Centaurus Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $881K | Buy |
6,319
+1,024
| +19% | +$143K | 0.04% | 377 |
|
|
2025
Q4 | $650K | Sell |
5,295
-1,697
| -24% | -$206K | 0.03% | 444 |
|
|
2025
Q3 | $776K | Buy |
6,992
+1,168
| +20% | +$133K | 0.04% | 398 |
|
|
2025
Q2 | $646K | Buy |
5,824
+731
| +14% | +$77.8K | 0.04% | 399 |
|
|
2025
Q1 | $571K | Buy |
5,093
+231
| +5% | +$23.8K | 0.03% | 419 |
|
|
2024
Q4 | $449K | Buy |
4,862
+1,332
| +38% | +$120K | 0.03% | 469 |
|
|
2024
Q3 | $296K | Sell |
3,530
-1,268
| -26% | -$96.8K | 0.02% | 540 |
|
|
2024
Q2 | $329K | Buy |
4,798
+529
| +12% | +$35.3K | 0.02% | 474 |
|
|
2024
Q1 | $313K | Sell |
4,269
-1,272
| -23% | -$97.8K | 0.02% | 491 |
|
|
2023
Q4 | $449K | Sell |
5,541
-674
| -11% | -$52.4K | 0.03% | 388 |
|
|
2023
Q3 | $466K | Buy |
6,215
+1,155
| +23% | +$88.8K | 0.04% | 369 |
|
|
2023
Q2 | $390K | Sell |
5,060
-2,702
| -35% | -$215K | 0.03% | 409 |
|
|
2023
Q1 | $644K | Buy |
7,762
+756
| +11% | +$62.6K | 0.05% | 331 |
|
|
2022
Q4 | $601K | Sell |
7,006
-1,849
| -21% | -$146K | 0.06% | 322 |
|
|
2022
Q3 | $546K | Buy |
8,855
+100
| +1% | +$6.31K | 0.05% | 335 |
|
|
2022
Q2 | $541K | Sell |
8,755
-1,822
| -17% | -$113K | 0.05% | 354 |
|
|
2022
Q1 | $629K | Buy |
10,577
+596
| +6% | +$38.1K | 0.05% | 370 |
|
|
2021
Q4 | $725K | Sell |
9,981
-1,779
| -15% | -$123K | 0.05% | 341 |
|
|
2021
Q3 | $821K | Buy |
11,760
+228
| +2% | +$16K | 0.07% | 310 |
|
|
2021
Q2 | $794K | Buy |
11,532
+1,587
| +16% | +$106K | 0.07% | 322 |
|
|
2021
Q1 | $643K | Buy |
9,945
+2,883
| +41% | +$186K | 0.06% | 313 |
|
|
2020
Q4 | $411K | Sell |
7,062
-905
| -11% | -$54.6K | 0.04% | 405 |
|
|
2020
Q3 | $503K | Sell |
7,967
-5,267
| -40% | -$365K | 0.07% | 274 |
|
|
2020
Q2 | $1.02M | Buy |
13,234
+6,937
| +110% | +$532K | 0.15% | 170 |
|
|
2020
Q1 | $471K | Sell |
6,297
-825
| -12% | -$57K | 0.09% | 216 |
|
|
2019
Q4 | $463K | Sell |
7,122
-558
| -7% | -$36.3K | 0.06% | 321 |
|
|
2019
Q3 | $487K | Buy |
7,680
+657
| +9% | +$42.9K | 0.08% | 272 |
|
|
2019
Q2 | $474K | Buy |
7,023
+6,568
| +1,444% | +$432K | 0.07% | 277 |
|
|
2019
Q1 | $7K | Buy |
455
+102
| +29% | +$6.78K | 0.04% | 313 |
|
|
2018
Q4 | $6 | Buy |
353
+346
| +4,943% | +$24.2K | 0.04% | 259 |
|
|
2018
Q3 | $507 | Sell |
7
-10,592
| -100% | -$800K | 0.09% | 242 |
|
|
2018
Q2 | $751K | Buy |
10,599
+4,946
| +87% | +$349K | 0.1% | 206 |
|
|
2018
Q1 | $426K | Buy |
5,653
+236
| +4% | +$18.8K | 0.1% | 220 |
|
|
2017
Q4 | $388K | Buy |
+5,417
| New | +$411K | 0.1% | 213 |
|
Other funds holding GILD
VCM
VPM
Centaurus Financial's GILD Position: Q1 2026 in Review
Centaurus Financial increased its Gilead Sciences (GILD) stake by 19% in Q1 2026, buying an estimated $143K and bringing the position to 6,319 shares worth $881K. The position accounts for 0.04% of the portfolio, ranked #377.
Centaurus Financial first reported a position in GILD in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.02M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Centaurus Financial held 6,319 shares of Gilead Sciences worth $881K as of Q1 2026.
- Centaurus Financial bought 1,024 Gilead Sciences shares in Q1 2026, an estimated $143K.
- Gilead Sciences made up 0.04% of Centaurus Financial's portfolio in Q1 2026, its #377 holding.
- Centaurus Financial first reported a position in Gilead Sciences in Q4 2017 and has held it in 34 quarters since.
- Centaurus Financial's Gilead Sciences position peaked at $1.02M in Q2 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.